ALSO NOTED: Nektar closes UK site; Martines resigns from NSP; and much more...

> Nektar Therapeutics has closed a site in the U.K. that employs 35 workers. Report

> Chutes & Ladders: Sergio Martines has resigned as a director, president and CEO of NSP Pharma. Release

> Inspire Pharmaceuticals has launched a Phase III clinical trial to evaluate its drug candidate, denufosol tetrasodium Inhalation Solution, in patients with mild cystic fibrosis lung disease. Release

> Pfizer has won conditional marketing approval from the EU for Sutent as a therapy against a type of advanced kidney cancer. Report

> UCB has submitted an NDA for the approval of Xyzal (levocetirizine dihydrochloride), a new prescription antihistamine for treatment of allergy symptoms. Release

> Glaxo is seeking marketing approval in the U.S. and Europe for a new medicine to treat the symptoms of seasonal allergic rhinitis and perennial allergic rhinitis. Release

And Finally… Researchers say they've found a second DNA code which may help illuminate how cells activate genes. Article